These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32377536)

  • 1. The Immunosuppressant Fingolimod (FTY720) for the Treatment of Mechanical Force-Induced Abnormal Scars.
    Aoki M; Kondo A; Matsunaga N; Honda A; Okubo Y; Takabe K; Ogawa R
    J Immunol Res; 2020; 2020():7057195. PubMed ID: 32377536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sphingosine-1-Phosphate Prevents Egress of Hematopoietic Stem Cells From Liver to Reduce Fibrosis.
    King A; Houlihan DD; Kavanagh D; Haldar D; Luu N; Owen A; Suresh S; Than NN; Reynolds G; Penny J; Sumption H; Ramachandran P; Henderson NC; Kalia N; Frampton J; Adams DH; Newsome PN
    Gastroenterology; 2017 Jul; 153(1):233-248.e16. PubMed ID: 28363640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the SphK1/S1P/S1PR1 Axis That Links Obesity, Chronic Inflammation, and Breast Cancer Metastasis.
    Nagahashi M; Yamada A; Katsuta E; Aoyagi T; Huang WC; Terracina KP; Hait NC; Allegood JC; Tsuchida J; Yuza K; Nakajima M; Abe M; Sakimura K; Milstien S; Wakai T; Spiegel S; Takabe K
    Cancer Res; 2018 Apr; 78(7):1713-1725. PubMed ID: 29351902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulating sphingosine 1-phosphate signaling with DOP or FTY720 alleviates vascular and immune defects in mouse sepsis.
    Hemdan NY; Weigel C; Reimann CM; Gräler MH
    Eur J Immunol; 2016 Dec; 46(12):2767-2777. PubMed ID: 27683081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sphingosine-1-phosphate receptor agonism impairs the efficiency of the local immune response by altering trafficking of naive and antigen-activated CD4+ T cells.
    Xie JH; Nomura N; Koprak SL; Quackenbush EJ; Forrest MJ; Rosen H
    J Immunol; 2003 Apr; 170(7):3662-70. PubMed ID: 12646631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial barrier protection by FTY720 under hyperglycemic condition: involvement of focal adhesion kinase, small GTPases, and adherens junction proteins.
    Sarai K; Shikata K; Shikata Y; Omori K; Watanabe N; Sasaki M; Nishishita S; Wada J; Goda N; Kataoka N; Makino H
    Am J Physiol Cell Physiol; 2009 Oct; 297(4):C945-54. PubMed ID: 19657053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention, but not cure, of autoimmune diabetes in a NOD.scid transfer model by FTY720 despite effective modulation of blood T cells.
    Morris MA; McDuffie M; Nadler JL; Ley K
    Autoimmunity; 2011 Mar; 44(2):115-28. PubMed ID: 20695767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FTY720 (Fingolimod) attenuates basal and sphingosine-1-phosphate-evoked thyroid cancer cell invasion.
    Kalhori V; Magnusson M; Asghar MY; Pulli I; Törnquist K
    Endocr Relat Cancer; 2016 May; 23(5):457-68. PubMed ID: 26935838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional characterization of sphingosine 1-phosphate receptor agonist in human endothelial cells.
    Butler J; Lana D; Round O; LaMontagne K
    Prostaglandins Other Lipid Mediat; 2004 Jan; 73(1-2):29-45. PubMed ID: 15165029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphingosine-1-phosphate receptor 1 agonism attenuates lung ischemia-reperfusion injury.
    Stone ML; Sharma AK; Zhao Y; Charles EJ; Huerter ME; Johnston WF; Kron IL; Lynch KR; Laubach VE
    Am J Physiol Lung Cell Mol Physiol; 2015 Jun; 308(12):L1245-52. PubMed ID: 25910934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FTY720/fingolimod decreases hepatic steatosis and expression of fatty acid synthase in diet-induced nonalcoholic fatty liver disease in mice.
    Rohrbach TD; Asgharpour A; Maczis MA; Montefusco D; Cowart LA; Bedossa P; Sanyal AJ; Spiegel S
    J Lipid Res; 2019 Jul; 60(7):1311-1322. PubMed ID: 31110049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pleiotropic FTY720 Is a Specific and Potent Therapy for Hypertrophic Scars.
    Shi F; Cao X; Hu Z; Ma D; Guo D; Zhang J; Zhang C; Liu P; Qu S; Zhu J; Deng W; Tang B
    J Invest Dermatol; 2017 Jul; 137(7):1552-1561. PubMed ID: 28288846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fingolimod protects against neonatal white matter damage and long-term cognitive deficits caused by hyperoxia.
    Serdar M; Herz J; Kempe K; Lumpe K; Reinboth BS; Sizonenko SV; Hou X; Herrmann R; Hadamitzky M; Heumann R; Hansen W; Sifringer M; van de Looij Y; Felderhoff-Müser U; Bendix I
    Brain Behav Immun; 2016 Feb; 52():106-119. PubMed ID: 26456693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Nofer JR; Bot M; Brodde M; Taylor PJ; Salm P; Brinkmann V; van Berkel T; Assmann G; Biessen EA
    Circulation; 2007 Jan; 115(4):501-8. PubMed ID: 17242282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of sphingosine 1-phosphate (S1P) receptor agonists FTY720 and CYM5442 on atherosclerosis development in LDL receptor deficient (LDL-R⁻/⁻) mice.
    Poti F; Costa S; Bergonzini V; Galletti M; Pignatti E; Weber C; Simoni M; Nofer JR
    Vascul Pharmacol; 2012 Aug; 57(1):56-64. PubMed ID: 22459073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production and release of sphingosine 1-phosphate and the phosphorylated form of the immunomodulator FTY720.
    Kihara A; Igarashi Y
    Biochim Biophys Acta; 2008 Sep; 1781(9):496-502. PubMed ID: 18555808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical treatment targeting sphingosine-1-phosphate and sphingosine lyase abrogates experimental allergic rhinitis in a murine model.
    Kleinjan A; van Nimwegen M; Leman K; Hoogsteden HC; Lambrecht BN
    Allergy; 2013 Feb; 68(2):204-12. PubMed ID: 23253209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A new therapeutic approach for autoimmune diseases by the sphingosine 1-phosphate receptor modulator, fingolimod (FTY720)].
    Chiba K
    Nihon Rinsho Meneki Gakkai Kaishi; 2009 Apr; 32(2):92-101. PubMed ID: 19404007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FTY720 impairs CD8 T-cell function independently of the sphingosine-1-phosphate pathway.
    Ntranos A; Hall O; Robinson DP; Grishkan IV; Schott JT; Tosi DM; Klein SL; Calabresi PA; Gocke AR
    J Neuroimmunol; 2014 May; 270(1-2):13-21. PubMed ID: 24680062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical application of sphingosine-1-phosphate and FTY720 attenuate allergic contact dermatitis reaction through inhibition of dendritic cell migration.
    Reines I; Kietzmann M; Mischke R; Tschernig T; Lüth A; Kleuser B; Bäumer W
    J Invest Dermatol; 2009 Aug; 129(8):1954-62. PubMed ID: 19194476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.